Non-stop dabigatran

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

From articulatory to acoustic parameters non-stop

This paper reports an attempt to map the time variations of selected articulatory parameters (from X-ray profiles) directly on the F1, F2 and F3 formant tracks using multiple regression analysis (MRA). The results indicate that MRA can indeed be useful for predicting formant frequencies. Since the results reported here are limited to preliminary observations of F1 only, further studies includin...

متن کامل

Development of Non-stop Automated Gate System

Most container terminals are still using a bar code system for gate passage of trucks and containers, and also using paper documents (slip) for the delivery of the information on storage location of container in a yard. For this reason, most trucks have to stop at the gate of the container terminals in order to perform several basic jobs. To enhance the productivity of gate management, this stu...

متن کامل

Dabigatran (Pradaxa).

Dabigatran (Pradaxa) is a member of the relatively new class of antithrombotic drugs known as direct thrombin inhibitors (DTIs). It may supplant warfarin (Coumadin) in a number of applications as it may produce a more predictable, potent, and immediate anticoagulant effect, with fewer significant side effects and interactions, and requires less monitoring.

متن کامل

Dabigatran-induced Exfoliative Esophagitis.

A 78-year-old-woman, with a history of non-valvular atrial fibrillation, had been taking dabigatran for twelve months and was referred to our hospital due to epigastralgia which was resistant to omeprazole administration. Esophagogastroduodenoscopy revealed longitudinal sloughing mucosal casts in the mid-esophagus (Picture 1, 2) without any remarkable findings in the esophagogastric junction, t...

متن کامل

The Dabigatran debate

In the June 2013 issue of this Journal, we described compelling evidence for the use of three novel anticoagulants, including Dabigatran, on the basis of recent large multi-centre trials. We acknowledged the approval of NOACs over warfarin in the ESC update and ACCP guidelines, and foresaw the greater usage of these newer, promising, therapies for stroke prevention in non-valvular atrial fibril...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: AboutOpen

سال: 2018

ISSN: 2465-2628

DOI: 10.19156/abtpn.2018.0066